166 related articles for article (PubMed ID: 34879794)
21. Differential roles for lysyl oxidase (like), family members in chronic obstructive pulmonary disease; from gene and protein expression to function.
Migulina N; Tjin G; Faiz A; Borghuis T; Zhao F; Kaper HJ; Metzlar M; van Dijk E; Sharma PK; Timens W; Gosens R; Brandsma CA; Burgess JK
FASEB J; 2022 Jul; 36(7):e22374. PubMed ID: 35670745
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta.
Behmoaras J; Slove S; Seve S; Vranckx R; Sommer P; Jacob MP
Rejuvenation Res; 2008 Oct; 11(5):883-9. PubMed ID: 18803461
[TBL] [Abstract][Full Text] [Related]
23. Lysyl Oxidases Expression and Breast Cancer Progression: A Bioinformatic Analysis.
Ramos S; Ferreira S; Fernandes AS; Saraiva N
Front Pharmacol; 2022; 13():883998. PubMed ID: 35800439
[TBL] [Abstract][Full Text] [Related]
24. Human lysyl oxidase-like 2.
Moon HJ; Finney J; Ronnebaum T; Mure M
Bioorg Chem; 2014 Dec; 57():231-241. PubMed ID: 25146937
[TBL] [Abstract][Full Text] [Related]
25. Lysyl oxidases in mammalian development and certain pathological conditions.
Mäki JM
Histol Histopathol; 2009 May; 24(5):651-60. PubMed ID: 19283672
[TBL] [Abstract][Full Text] [Related]
26. Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.
Trackman PC
Expert Opin Ther Targets; 2016 Aug; 20(8):935-45. PubMed ID: 26848785
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
28. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
[TBL] [Abstract][Full Text] [Related]
29. LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung.
Ma HY; Li Q; Wong WR; N'Diaye EN; Caplazi P; Bender H; Huang Z; Arlantico A; Jeet S; Wong A; Emson C; Brightbill H; Tam L; Newman R; Roose-Girma M; Sandoval W; Ding N
Sci Adv; 2023 May; 9(21):eadf0133. PubMed ID: 37235663
[TBL] [Abstract][Full Text] [Related]
30. Lysyl oxidase expression and collagen cross-linking during chronic adriamycin nephropathy.
Di Donato A; Ghiggeri GM; Di Duca M; Jivotenko E; Acinni R; Campolo J; Ginevri F; Gusmano R
Nephron; 1997; 76(2):192-200. PubMed ID: 9200411
[TBL] [Abstract][Full Text] [Related]
31. Targeting the lysyl oxidases in tumour desmoplasia.
Chitty JL; Setargew YFI; Cox TR
Biochem Soc Trans; 2019 Dec; 47(6):1661-1678. PubMed ID: 31754702
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.
Fujimoto E; Tajima S
J Dermatol Sci; 2009 Aug; 55(2):91-8. PubMed ID: 19394199
[TBL] [Abstract][Full Text] [Related]
33. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.
Iftikhar M; Hurtado P; Bais MV; Wigner N; Stephens DN; Gerstenfeld LC; Trackman PC
J Biol Chem; 2011 Jan; 286(2):909-18. PubMed ID: 21071451
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
35. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
[TBL] [Abstract][Full Text] [Related]
36. Disulfiram prevents collagen crosslinking and inhibits renal fibrosis by inhibiting lysyl oxidase enzymes.
Saifi MA; Shaikh AS; Kaki VR; Godugu C
J Cell Physiol; 2022 May; 237(5):2516-2527. PubMed ID: 35285015
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Interplay between Polyphenols and Lysyl Oxidase Enzymes for Maintaining Extracellular Matrix Homeostasis.
Añazco C; Riedelsberger J; Vega-Montoto L; Rojas A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446164
[TBL] [Abstract][Full Text] [Related]
38. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
39. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.
Busnadiego O; Gorbenko Del Blanco D; González-Santamaría J; Habashi JP; Calderon JF; Sandoval P; Bedja D; Guinea-Viniegra J; Lopez-Cabrera M; Rosell-Garcia T; Snabel JM; Hanemaaijer R; Forteza A; Dietz HC; Egea G; Rodriguez-Pascual F
J Mol Cell Cardiol; 2015 Aug; 85():48-57. PubMed ID: 25988230
[TBL] [Abstract][Full Text] [Related]
40. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
